Curr Atheroscler Rep (2011) 13:257–265 in humans. J Clin Invest. 2009;119:1042–50. This is an important study demonstrating that endothelial lipase is a negative regulator of HDL plasma levels in humans using an experimental approach that combines human genetics with in vitro work and proof-of- concept studies in experimental animals. 35. Brown RJ, Edmondson AC, Griffon N, et al. A naturally occurring variant of endothelial lipase associated with elevated HDL exhibits impaired synthesis. J Lipid Res. 2009;50:1910– 6. 36. Paradis ME, Couture P, Bosse Y, et al. The T111I mutation in the EL gene modulates the impact of dietary fat on the HDL profile in women. J Lipid Res. 2003;44:1902–8. 37. Halverstadt A, Phares DA, Ferrell RE, et al. High-density lipoprotein-cholesterol, its subfractions, and responses to exercise training are dependent on endothelial lipase genotype. Metabo- lism. 2003;52:1505–11. 38. Qiu G, Hill JS. Endothelial lipase promotes apolipoprotein AI- mediated cholesterol efflux in THP-1 macrophages. Arterioscler Thromb Vasc Biol. 2009;29:84–91. 39. Gauster M, Oskolkova OV, Innerlohinger J, et al. Endothelial lipase-modified high-density lipoprotein exhibits diminished ability to mediate SR-BI (scavenger receptor B type I)-dependent free-cholesterol efflux. Biochem J. 2004;382:75–82. 40. Yancey PG, Kawashiri MA, Moore R, et al. In vivo modulation of HDL phospholipid has opposing effects on SR-BI- and ABCA1- mediated cholesterol efflux. J Lipid Res. 2004;45:337–46. 41. Strauss JG, Zimmermann R, Hrzenjak A, et al. Endothelial cell- derived lipase mediates uptake and binding of high-density lipoprotein (HDL) particles and the selective uptake of HDL- 265 associated cholesterol esters independent of its enzymic activity. Biochem J. 2002;368:69–79. 42. Jin W, Wang X, Millar JS, et al. Hepatic proprotein convertases modulate HDL metabolism. Cell Metab. 2007;6:129–36. 43. Ishida T, Choi SY, Kundu RK, et al. Endothelial lipase modulates susceptibility to atherosclerosis in apolipoprotein-E-deficient mice. J Biol Chem. 2004;279:45085–92. 44. Ko KW, Paul A, Ma K, et al. Endothelial lipase modulates HDL but has no effect on atherosclerosis development in apoE−/− and LDLR−/− mice. J Lipid Res. 2005;46:2586–94. 45. van der Giet M, Tolle M, Pratico D, et al. Increased type IIA secretory phospholipase A(2) expression contributes to oxidative stress in end-stage renal disease. J Mol Med. 2010;88:75–83. 46. Fujii H, Fukuda A, Tanaka M, et al. Putative role of endothelial lipase in dialysis patients with hypoalbuminemia and inflamma- tion. Am J Nephrol. 2008;28:974–81. 47. Shimizu M, Kanazawa K, Hirata K, et al. Endothelial lipase gene polymorphism is associated with acute myocardial infarction, independently of high-density lipoprotein-cholesterol levels. Circ J. 2007;71:842–6. 48. Tang NP, Wang LS, Yang L, et al. Protective effect of an endothelial lipase gene variant on coronary artery disease in a Chinese population. J Lipid Res. 2008;49:369–75. 49. Jensen MK, Rimm EB, Mukamal KJ, et al. The T111I variant in the endothelial lipase gene and risk of coronary heart disease in three independent populations. Eur Heart J. 2009;30:1584–9. 50. Vergeer M, Cohn DM, Boekholdt SM, et al. Lack of association between common genetic variation in endothelial lipase (LIPG) and the risk for CAD and DVT. Atherosclerosis. 2010;211:558–64.